6 research outputs found
Complex movement disorders at disease onset in childhood narcolepsy with cataplexy
Narcolepsy with cataplexy is characterized by daytime sleepiness, cataplexy (sudden loss of bilateral muscle tone triggered by emotions), sleep paralysis, hypnagogic hallucinations and disturbed nocturnal sleep. Narcolepsy with cataplexy is most often associated with human leucocyte antigen-DQB1*0602 and is caused by the loss of hypocretin-producing neurons in the hypothalamus of likely autoimmune aetiology. Noting that children with narcolepsy often display complex abnormal motor behaviours close to disease onset that do not meet the classical definition of cataplexy, we systematically analysed motor features in 39 children with narcolepsy with cataplexy in comparison with 25 age- and sex-matched healthy controls. We found that patients with narcolepsy with cataplexy displayed a complex array of ‘negative’ (hypotonia) and ‘active’ (ranging from perioral movements to dyskinetic–dystonic movements or stereotypies) motor disturbances. ‘Active’ and ‘negative’ motor scores correlated positively with the presence of hypotonic features at neurological examination and negatively with disease duration, whereas ‘negative’ motor scores also correlated negatively with age at disease onset. These observations suggest that paediatric narcolepsy with cataplexy often co-occurs with a complex movement disorder at disease onset, a phenomenon that may vanish later in the course of the disease. Further studies are warranted to assess clinical course and whether the associated movement disorder is also caused by hypocretin deficiency or by additional neurochemical abnormalities
Population synthesis at short wavelengths and spectrophotometric diagnostic tools for galaxy evolution
Summary. Taking advantage of recent important advances in the calculation of high-resolution spectral grids of stellar atmospheres at short-wavelengths, and their implementation for population synthesis models, we briefly review here some special properties of ultraviolet emission in SSPs, and discuss their potential applications for identifying and tuning up effective diagnostic tools to probe distinctive evolutionary properties of early-type galaxies and other evolved stellar systems
High Resolution Spectral Line Indices Useful for the Analysis of Stellar Populations
International audienceThe well-known age-metallicity-attenuation degeneracy does not permit unique and good estimates of basic parameters of stars and stellar populations. The effects of dust can be avoided using spectral line indices, but current methods have not been able to break the age-metallicity degeneracy. Here we show that using at least two new spectral line indices defined and measured on high-resolution (R= 6000) spectra of a signal-to-noise ratio (S/N) ≥ 10 one gets unambiguous estimates of the age and metallicity of intermediate to old stellar populations. Spectroscopic data retrieved with new astronomical facilities, e.g., X-shooter, MEGARA, and MOSAIC, can be employed to infer the physical parameters of the emitting source by means of spectral line index and index-index diagram analysis
First scientific observations with MEGARA at GTC
On June 25th 2017, the new intermediate-resolution optical IFU and MOS of the 10.4-m GTC had its first light. As part of the tests carried out to verify the performance of the instrument in its two modes (IFU and MOS) and 18 spectral setups (identical number of VPHs with resolutions R=6000-20000 from 0.36 to 1 micron) a number of astronomical objects were observed. These observations show that MEGARA@GTC is called to fill a niche of high-throughput, intermediateresolution IFU and MOS observations of extremely-faint narrow-lined objects. Lyman-α absorbers, star-forming dwarfs or even weak absorptions in stellar spectra in our Galaxy or in the Local Group can now be explored to a new level. Thus, the versatility of MEGARA in terms of observing modes and spectral resolution and coverage will allow GTC to go beyond current observational limits in either depth or precision for all these objects. The results to be presented in this talk clearly demonstrate the potential of MEGARA in this regard
Recommended from our members
The Telescopio San Pedro Mártir project
The Telescopio San Pedro Martir project intends to construct a 6.5m telescope to be installed at the Observatorio Astronomico Nacional in the Sierra San Pedro Martir in northern Baja California, Mexico. The project is an association of Mexican institutions, lead by the Instituto Nacional de Astrofisica,Optica y Electronica and UNAM's Instituto de Astronomia, in partnership with the Smithsonian Astrophysical Observatory and the University of Arizona's Department of Astronomy and Steward Observatory. The project is advancing through the design stage, having completed five design reviews of different subsystems in 2016 and 2017 (enclosure and services: PDR, CDR; optical design: PDR; optics: progress review; telescope: PDR). Once completed, the partners plan to operate the MMT and TSPM as a binational astrophysical observatory.Mexico by the IA-UNAM; INAOE; Consejo Nacional de Ciencia y Tecnologia [LN 127736, LN 232649, LN 260369, LN 271117, LN 280035, 224003, 264173, 272027, 279517, 293074]; Agencia Espacial Mexicana [248500]This item from the UA Faculty Publications collection is made available by the University of Arizona with support from the University of Arizona Libraries. If you have questions, please contact us at [email protected]
Effect of the COVID-19 pandemic on surgery for indeterminate thyroid nodules (THYCOVID): a retrospective, international, multicentre, cross-sectional study
Background: Since its outbreak in early 2020, the COVID-19 pandemic has diverted resources from non-urgent and elective procedures, leading to diagnosis and treatment delays, with an increased number of neoplasms at advanced stages worldwide. The aims of this study were to quantify the reduction in surgical activity for indeterminate thyroid nodules during the COVID-19 pandemic; and to evaluate whether delays in surgery led to an increased occurrence of aggressive tumours.
Methods: In this retrospective, international, cross-sectional study, centres were invited to participate in June 22, 2022; each centre joining the study was asked to provide data from medical records on all surgical thyroidectomies consecutively performed from Jan 1, 2019, to Dec 31, 2021. Patients with indeterminate thyroid nodules were divided into three groups according to when they underwent surgery: from Jan 1, 2019, to Feb 29, 2020 (global prepandemic phase), from March 1, 2020, to May 31, 2021 (pandemic escalation phase), and from June 1 to Dec 31, 2021 (pandemic decrease phase). The main outcomes were, for each phase, the number of surgeries for indeterminate thyroid nodules, and in patients with a postoperative diagnosis of thyroid cancers, the occurrence of tumours larger than 10 mm, extrathyroidal extension, lymph node metastases, vascular invasion, distant metastases, and tumours at high risk of structural disease recurrence. Univariate analysis was used to compare the probability of aggressive thyroid features between the first and third study phases. The study was registered on ClinicalTrials.gov, NCT05178186.
Findings: Data from 157 centres (n=49 countries) on 87 467 patients who underwent surgery for benign and malignant thyroid disease were collected, of whom 22 974 patients (18 052 [78·6%] female patients and 4922 [21·4%] male patients) received surgery for indeterminate thyroid nodules. We observed a significant reduction in surgery for indeterminate thyroid nodules during the pandemic escalation phase (median monthly surgeries per centre, 1·4 [IQR 0·6-3·4]) compared with the prepandemic phase (2·0 [0·9-3·7]; p<0·0001) and pandemic decrease phase (2·3 [1·0-5·0]; p<0·0001). Compared with the prepandemic phase, in the pandemic decrease phase we observed an increased occurrence of thyroid tumours larger than 10 mm (2554 [69·0%] of 3704 vs 1515 [71·5%] of 2119; OR 1·1 [95% CI 1·0-1·3]; p=0·042), lymph node metastases (343 [9·3%] vs 264 [12·5%]; OR 1·4 [1·2-1·7]; p=0·0001), and tumours at high risk of structural disease recurrence (203 [5·7%] of 3584 vs 155 [7·7%] of 2006; OR 1·4 [1·1-1·7]; p=0·0039).
Interpretation: Our study suggests that the reduction in surgical activity for indeterminate thyroid nodules during the COVID-19 pandemic period could have led to an increased occurrence of aggressive thyroid tumours. However, other compelling hypotheses, including increased selection of patients with aggressive malignancies during this period, should be considered. We suggest that surgery for indeterminate thyroid nodules should no longer be postponed even in future instances of pandemic escalation.
Funding: None